Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
parkinson's neuritis neuralgia myasthenia gravis lactic acidosis ataxia seizure tinnitus migraine hypotoniaYour Article Summary
Diagnosis and Management of Progressive Supranuclear Palsy
Geriatrics & Aging, 08/31/09
Gupta A et al. – Progressive supranuclear palsy (PSP) is a rare, fatal neurodegenerative disease with limited treatment options that is characterized by gait and postural instability and a classical vertical supranuclear gaze palsy. Initially often misdiagnosed as idiopathic Parkinson’s disease (IPD), proper patient care in PSP may be delayed until late into the disease course, after dopaminergic medication fails to improve symptoms. Here, the authors review the diagnostic criteria that help to separate PSP from IPD and rarer forms of parkinsonian diseases to help clinicians with earlier recognition. The authors discuss current treatment concepts as well as ongoing experimental approaches that are derived from an emerging pathological understanding.
Related Articles
Repetitive transcranial magnetic stimulation in patients with progressive supranuclear palsy: a pilot study
Acta Neurologica Belgica, 10/21/09
Relevance Score: 81%
Exodeviated Ophthalmoplegia in a Patient with Progressive Supranuclear Palsy
Journal of Korean Medical Science, 10/06/09
Relevance Score: 81%
Autobiographical memory in progressive supranuclear palsy
European Journal of Neurology, 10/02/09
Relevance Score: 80%
The diagnostic dilemma of neuro-imaging in acute isolated sixth nerve palsy
Current Opinion in Ophthalmology, 10/27/09
Relevance Score: 66%
Cervical Cord Injury in Patients With Ankylosed Spines: Progressive Paraplegia in Two Patients After Posterior Fusion Without Decompression
Spine, 11/06/09
Relevance Score: 64%
Today in Movement Disorders...keeping you current
Receive free subspecialty "5-minute updates" via email
Pregabalin-Induced Parkinsonism: A Case Report
Clinical Neuropharmacology, 12/16/09
Urate as a Predictor of the Rate of Clinical Decline in Parkinson Disease
Archives of Neurology, 12/16/09
Pain after paraplegia: a survey in India
Spinal Cord, 12/16/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


